Corrigendum

This article refers to:

Efavirenz-Loaded Polymeric Micelles for Pediatric Anti-HIV Pharmacotherapy with Significantly Higher Oral Bioavailability

In the Research Article by Diego A Chiappetta, Christian Hocht, Carlos Taira and Alejandro Sosnik, Efavirenz-loaded polymeric micelles for pediatric anti-HIV pharmacotherapy with significantly higher oral bioavailability (Nanomedicine 5[1], 11–23 [2010]), on page 16, Table 1 was originally printed as:

Table 3. Pharmacokinetic parameters of the different 20 mg/ml efavirenz formulations administered orally.

Parameter	EFV-loaded micelles		EFV suspension			EFV triglyceride solution
	Mean	CV %		Mean	CV %	p-value		Mean	CV%	p-value
Cmax (ng/ml)	2863*	28.3		1526*	42.2	0.002		1789*	61.4	0.04
tmax (min)	2.85	40.5		2.38	50.0	–		2.42	53.0	–
AUC (mg/ml/h)	23.5^‡	37.1		15.1^‡	55.2	0.050		12.6^‡	49.0	0.018

*C_max of EFV micellar system is significantly higher than the suspension and the oil solution.

^‡ AUC of EFV micellar system is significantly higher than the suspension and the oil solution.

AUC: Area under curve; CV%: Coefficient of variation; EFV: Efavirenz.

The correct table is given below:

Table 3. Pharmacokinetic parameters of the different 20 mg/ml efavirenz formulations administered orally.

Parameter	EFV-loaded micelles		EFV suspension			EFV triglyceride solution
	Mean	CV %		Mean	CV %	p-value		Mean	CV%	p-value
Cmax (ng/ml)	2863*	28.3		1526*	42.2	0.002		1789*	61.4	0.04
tmax (h)	2.85	40.5		2.38	50.0	–		2.42	53.0	–
AUC (mg/ml/h)	23.5^‡	37.1		15.1^‡	55.2	0.050		12.6^‡	49.0	0.018

*C_max of EFV micellar system is significantly higher than the suspension and the oil solution.

^‡ AUC of EFV micellar system is significantly higher than the suspension and the oil solution.

AUC: Area under curve; CV%: Coefficient of variation; EFV: Efavirenz.

The authors would like to sincerely apologize for any inconvenience or confusion this may have caused our readers.